Skip to content

Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus

Nitazoxanide vs Probiotics in the Treatment of Acute Rotavirus Diarrhea in Children: A Randomized Single Blind Controlled Trial in Bolivian Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00683982
Enrollment
75
Registered
2008-05-26
Start date
2007-08-31
Completion date
2008-05-31
Last updated
2008-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea, Rotavirus Infection

Keywords

nitazoxanide, Probiotics, Diarrhea, Rotavirus, Children

Brief summary

Nitazoxanide has proved an cytoprotective effect against rotavirus infection. How it could be clinically important in time of hospitalization and reduction of duration of diarrhea secondary to rotavirus?

Detailed description

Nitazoxanide has demonstrated a cytoprotective effect against rotavirus, reducing duration time of diarrhea in comparison to placebo in previous studies. In the current study, based in those results, we design a randomized single-blind controlled trial, in order to asses the effectiveness of nitazoxanide and probiotics in comparison with a control group

Interventions

DRUGNitazoxanide

Nitazoxanide 15mg/Kg/day twice day for 3 days

Probiotic preparation 1 gram twice a day for 5 days

OTHEROral hydration solutions

Oral hydration solutions as needed

Sponsors

Centro Pediatrico Albina de Patino
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
28 Days to 24 Months
Healthy volunteers
No

Inclusion criteria

* Positive stool sample for rotavirus test

Exclusion criteria

* Severe malnourishment * Severe dehydration * History of diarrhea more than 3 days previous hospitalization * Use of antibiotics, probiotics or nitazoxanide 3 weeks before admission * Systemic infections * Severe chronic disease * Mixed enteric infections besides rotavirus

Design outcomes

Primary

MeasureTime frame
Duration of diarrheaHours

Secondary

MeasureTime frame
Duration of hospitalizationhours

Countries

Bolivia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026